News Headlines Article

Merck Wins Two Patent Lawsuits
New York Times

Merck & Company says it won two patent infringement lawsuits against Mylan Pharmaceuticals, a leading generic drug maker, which is seeking to make generic versions of Merck’s lucrative cholesterol pills, Zetia and Vytorin. Judge Jose L. Linares of Federal District Court in Newark ruled on Friday against Mylan, Merck said in a statement.

Both lawsuits concern the patent for ezetimibe, Zetia’s active ingredient and a part of Vytorin, which also includes generic Zocor. That is an older Merck cholesterol pill that works differently.